India’s pharmaceutical sector is under serious scrutiny as the World Health Organisation (WHO) has warned of a potential link of four cough syrups manufactured by a Haryana-based Company to the deaths of 66 children in the West African nation of Gambia. This is perhaps the first time that an inquiry has been initiated by WHO against an Indian drug manufacturing company. Apart from WHO, the Central Drugs Standard Control Organisation (CDSCO) is also investigating whether contaminated materials were used in preparing the cough syrups. It is hoped that both inquiries will be completed soon and the guilty parties served exemplary punishment for taking innocent lives. Leniency shown towards the culprits will deeply hurt the reputation of the country. At the same time, the incident may cripple the $40 billion Indian pharmaceutical industry as nearly half of its annual income comes from exporting drugs to foreign countries. It should be noted that over the years India’s pharmaceutical ind